Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 11.2B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Calliditas Therapeutics AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Calliditas Therapeutics AB
Operating Income Peer Comparison

Comparables:
CAMX
S
SECARE
IRLAB A
MOB
I
FLERIE

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Calliditas Therapeutics AB
STO:CALTX
Operating Income
-kr353.1m
CAGR 3-Years
14%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Operating Income
kr236.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Operating Income
kr224.5m
CAGR 3-Years
57%
CAGR 5-Years
45%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Operating Income
-kr180.8m
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Operating Income
-kr27.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Operating Income
-kr238.9m
CAGR 3-Years
-51%
CAGR 5-Years
-27%
CAGR 10-Years
N/A

See Also

What is Calliditas Therapeutics AB's Operating Income?
Operating Income
-353.1m SEK

Based on the financial report for Jun 30, 2024, Calliditas Therapeutics AB's Operating Income amounts to -353.1m SEK.

What is Calliditas Therapeutics AB's Operating Income growth rate?
Operating Income CAGR 5Y
-60%

Over the last year, the Operating Income growth was -36%. The average annual Operating Income growth rates for Calliditas Therapeutics AB have been 14% over the past three years , -60% over the past five years .

Back to Top